Literature DB >> 19362571

Is the origin of the hemianopic line bisection error purely visual? Evidence from eye movements in simulated hemianopia.

Susanne Schuett1, Robert W Kentridge, Josef Zihl, Charles A Heywood.   

Abstract

It is still unclear whether the contralateral line bisection error in unilateral homonymous hemianopia is caused by the visual field defect, strategic oculomotor adaptation or by additional extrastriate brain injury. We therefore simulated hemianopia in healthy participants using a gaze-contingent display paradigm and investigated its effects on manual and ocular line bisection performance and eye-movements. Although simulated hemianopia impaired line bisection and induced the adaptive oculomotor eye-movement pattern of hemianopic patients, it did not induce the contralateral bisection error, suggesting that neither the visual field defect nor oculomotor adaptation to it are the primary causes of the hemianopic bisection error.

Entities:  

Mesh:

Year:  2009        PMID: 19362571     DOI: 10.1016/j.visres.2009.04.004

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  4 in total

1.  Examining the influence of 'noise' on judgements of spatial extent.

Authors:  Derick F Valadao; Marc Hurwitz; James Danckert
Journal:  Exp Brain Res       Date:  2010-10-16       Impact factor: 1.972

2.  Static versus dynamic judgments of spatial extent.

Authors:  Marc Hurwitz; Derick Valadao; James Danckert
Journal:  Exp Brain Res       Date:  2011-01-29       Impact factor: 1.972

3.  Biomechanical adaptation to post-stroke visual field loss: a systematic review.

Authors:  Adel Elfeky; Kristiaan D'Août; Rebecca Lawson; Lauren R Hepworth; Nicholas D A Thomas; Abigail Clynch; Fiona J Rowe
Journal:  Syst Rev       Date:  2021-03-27

4.  Bisecting or not bisecting: this is the neglect question. Line bisection performance in the diagnosis of neglect in right brain-damaged patients.

Authors:  Paola Guariglia; Alessandro Matano; Laura Piccardi
Journal:  PLoS One       Date:  2014-06-17       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.